MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.58

+1.4%

Nov 5 12:44 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (688)	6/20/2003 8:34:58 AM
From: Icebrg	Read Replies (3) of 2240

Re: HuMax-IL15 [Someone wiser than me made the following comments to the HuMax-IL15 results at Yahoo's Medarex board. Makes a lot of sense.] by: cytokine_release_syndrome (F/Aspen, On the Slopes) 06/20/03 07:29 am Msg: 75521 of 75523 erik_97 the results cannot be interpreted due to a poor study design. the subjects continued into repeated dosing in an open label fashion. the placebo effect in an open label design is tremendous in a ra trial. furthermore, they used a pooled analysis from all dose groups, suggesting a lack of dose response. this could be consistent with placebo effect. we will have to wait until the results of a properly designed study are available.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next